145 related articles for article (PubMed ID: 8630273)
21. [Safety and efficacy of hypotonic CDDP intraperitoneal administration for gastric cancer with peritoneal dissemination].
Bamba T; Kanda T; Ohashi M; Hanyu T; Sakamoto K; Ishikawa T; Yajima K; Makino S; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1695-7. PubMed ID: 16315912
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer.
Ansaloni L; Coccolini F; Morosi L; Ballerini A; Ceresoli M; Grosso G; Bertoli P; Busci LM; Lotti M; Cambria F; Pisano M; Rossetti D; Frigerio L; D'Incalci M; Zucchetti M
Br J Cancer; 2015 Jan; 112(2):306-12. PubMed ID: 25461804
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of intraoperative intrapleural cisplatin chemotherapy of various osmolarities in cases of esophageal cancer.
Katano K; Tsujitani S; Maeta M; Fukuda K; Oka S; Hisamitsu K; Ikeguchi M; Kaibara N
Oncol Rep; 2001; 8(3):605-9. PubMed ID: 11295088
[TBL] [Abstract][Full Text] [Related]
24. Pre-clinical study of the epinephrine-cisplatin association for the treatment of intraperitoneal carcinomatosis.
Favoulet P; Magnin G; Guilland JC; Beltramo JL; Osmak L; Benoit L; Rat P; Douvier S; Duvillard C; Chauffert B
Eur J Surg Oncol; 2001 Feb; 27(1):59-64. PubMed ID: 11237494
[TBL] [Abstract][Full Text] [Related]
25. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
[TBL] [Abstract][Full Text] [Related]
26. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
[TBL] [Abstract][Full Text] [Related]
27. Acute toxicity of long-circulating and pH-sensitive liposomes containing cisplatin in mice after intraperitoneal administration.
Leite EA; Giuberti Cdos S; Wainstein AJ; Wainstein AP; Coelho LG; Lana AM; Savassi-Rocha PR; De Oliveira MC
Life Sci; 2009 May; 84(19-20):641-9. PubMed ID: 19302806
[TBL] [Abstract][Full Text] [Related]
28. An experimental study of regional chemotherapy using CDDP-loaded microspheres for esophageal cancer.
Nakamura Y; Hamabe Y; Ikuta H; Hyon SH; Kuroda Y
Surg Today; 2002; 32(4):335-42. PubMed ID: 12027199
[TBL] [Abstract][Full Text] [Related]
29. Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study.
Li PC; Chen LD; Zheng F; Li Y
J Cancer Res Clin Oncol; 2008 Jan; 134(1):37-44. PubMed ID: 17665213
[TBL] [Abstract][Full Text] [Related]
30. Organ distribution of cisplatin after intraperitoneal administration of cisplatin-loaded microspheres.
Tamura T; Imai J; Matsumoto A; Tanimoto M; Suzuki A; Horikiri Y; Suzuki T; Yoshino H; Ike O
Eur J Pharm Biopharm; 2002 Jul; 54(1):1-7. PubMed ID: 12084496
[TBL] [Abstract][Full Text] [Related]
31. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.
Esquis P; Consolo D; Magnin G; Pointaire P; Moretto P; Ynsa MD; Beltramo JL; Drogoul C; Simonet M; Benoit L; Rat P; Chauffert B
Ann Surg; 2006 Jul; 244(1):106-12. PubMed ID: 16794395
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic behaviour of cisplatin in peritoneal fluid after intraperitoneal administration of cisplatin-loaded microspheres.
Tamura T; Imai J; Matsukawa Y; Horikiri Y; Suzuki T; Yoshino H; Ike O
J Pharm Pharmacol; 2001 Oct; 53(10):1331-9. PubMed ID: 11697540
[TBL] [Abstract][Full Text] [Related]
33. [Experimental study of cisplatin microspheres incorporated in polylactic acid and polyethylene glycol acid on peritoneal carcinomatosis in rats].
Tokuda K; Natsugoe S; Shimada M; Kumanohoso T; Yoshizawa H; Uemura Y; Hatate Y; Nakamura K; Yamada K; Nedachi M; Aiko T
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1516-8. PubMed ID: 8854794
[TBL] [Abstract][Full Text] [Related]
34. [Repeated intraperitoneal injection of low-dose CDDP for gastric cancer with ascites owing to peritonitis carcinomatosa].
Nakagawa M; Ninomiya M; Fujita I; Matsubara M; Okamoto Y; Kawamoto H; Araki Y; Inoue J; Sasaki H; Takakura N
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2346-9. PubMed ID: 12484071
[TBL] [Abstract][Full Text] [Related]
35. [Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer].
Yonemura Y; Endou Y; Tochiori S; Bando E; Kawamura T; Shimada T; Miyamoto K; Tanaka M; Sasaki T
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1635-9. PubMed ID: 16315893
[TBL] [Abstract][Full Text] [Related]
36. [Scanning electron microscopic observation of mouse ascitic carcinoma cells after intraperitoneal chemotherapy with cisplatinum].
Kurokawa T; Tamakuma S; Ohsaki Y
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1447-53. PubMed ID: 2809375
[TBL] [Abstract][Full Text] [Related]
37. Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity.
Leite EA; Souza CM; Carvalho-Júnior AD; Coelho LG; Lana AM; Cassali GD; Oliveira MC
Int J Nanomedicine; 2012; 7():5259-69. PubMed ID: 23091378
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin combined with prostaglandin E1 chemotherapy in rat peritoneal carcinomatosis.
Ikeguchi M; Maeta M; Kaibara N
Int J Cancer; 2000 Nov; 88(3):474-8. PubMed ID: 11054679
[TBL] [Abstract][Full Text] [Related]
39. [Intraoperative intraperitoneal chemoperfusion treatment with cisplatin and dioxadet on a model of peritoneal carcinomatosis in ovarian cancer: safety and efficacy evaluation].
Bespalov VG; Kireeva GS; Belyaeva OA; Senchik KY; Stukov AN; Gafton GI; Soloviev LA; Vasilchenko MV; Guseinov KD; Alexeev VV; Belyaev AM
Vopr Onkol; 2015; 61(4):647-52. PubMed ID: 26571838
[TBL] [Abstract][Full Text] [Related]
40. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.
Los G; Mutsaers PH; Lenglet WJ; Baldew GS; McVie JG
Cancer Chemother Pharmacol; 1990; 25(6):389-94. PubMed ID: 2311166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
